Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Finranks

Kompaniya

  • Biz haqimizda

Biz bilan bog'lanish

  • [email protected]

Bizni kuzating

  • Instagram
  • Telegram
  • LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari
  • Bosh sahifa
  • Bozorlar
  • Skriner
  • Yangiliklar
  • Biz haqimizda
  1. Home
  2. RARE
U

Ultragenyx Pharmaceutical Inc. (RARE)

19.38

0.00 (0.00%)

  • Umumiy
  • Yangiliklar
  • Grafik
  • Hisobotlar
  • Dividendlar
  • Kutilma
  • Egalik
  • Profil

Aksiya prognozi

Narx kutilmasi

This stock has a consensus price target of $75.89 based on the ratings of 27 analysts. The high is $140.00 and the low is $25.00.

Tahlilchi reytingi: Sotib olish

Narx dinamikasi + yillik prognoz

MaqsadMin. maqsadli narxO‘rtacha maqsadli narxMaks. maqsadli narx
Narx$ 25$ 75.89$ 140
O’zgarish29.00%291.59%622.39%

So'nggi kutilmalar

SanaO‘sish/pasayish potensialiTahlilchi firmasiMaqsadli narxReyting o‘zgarishiReyting
2026-03-12281.84%JP Morgan$120 → $74MaintainsOverweight
2026-02-18307.64%Canaccord Genuity$128 → $79MaintainsBuy
2026-02-1875.44%Evercore ISI Group$37 → $34MaintainsOutperform
2026-02-1790.92%Evercore ISI Group$39 → $37MaintainsOutperform
2026-02-1729%Wedbush$25 → $25ReiteratesNeutral

Har bir dona aksiyaga nisbatan foyda (EPS)

Daromad